Lifecore Biomedical, Inc. De (LFCR) Capital Expenditures (2010 - 2025)

Lifecore Biomedical's Capital Expenditures history runs 16 years deep, the most recent figure standing at $2.1 million for Q2 2025.

• In Q2 2025, Capital Expenditures fell 22.71% year-over-year to $2.1 million; the TTM figure through May 2025 stood at $13.4 million (down 27.07% YoY), while the FY2025 annual figure was $13.4 million, down 27.07% from the prior year.
• Capital Expenditures was $2.1 million for Q2 2025 at Lifecore Biomedical, down from $5.5 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $8.5 million in Q3 2021 to a low of -$7.4 million in Q4 2021.
• Historically, Capital Expenditures has averaged $3.3 million across 5 years, with a median of $3.5 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Capital Expenditures sank 122.77% in 2021, then jumped 1346.17% in 2023.
• A 5-year view of Capital Expenditures shows it stood at -$7.4 million in 2021, then soared by 167.51% to $5.0 million in 2022, then retreated by 14.2% to $4.3 million in 2023, then tumbled by 42.74% to $2.4 million in 2024, then dropped by 14.06% to $2.1 million in 2025.
• The last three Capital Expenditures figures came in at $2.1 million (Q2 2025), $5.5 million (Q1 2025), and $2.4 million (Q4 2024), per Business Quant data.